Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)
Abstract Objective Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and serious side effect of many cytotoxic drugs, including paclitaxel. Despite the identification of treatment options in animal models, clinical trials for the treatment or prevention of CIPN have been negative. Majo...
Saved in:
| Main Authors: | Wolfgang Boehmerle, Tim Hagenacker, Markus Leo, Linda-Isabell Schmitt, Helmar C. Lehmann, Ines Klein, Regina Stegherr, Frank Konietschke, Matthias Endres, Petra Huehnchen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Research Notes |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13104-025-07206-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Translating Basic Science to Clinical Applications: A Narrative Review of Repurposed Pharmacological Agents in Preclinical Models of Diabetic Neuropathy
by: Corina Andrei, et al.
Published: (2025-07-01) -
Preclinical systematic review of CCR5 antagonists as cerebroprotective and stroke recovery enhancing agents
by: Ayni Sharif, et al.
Published: (2025-04-01) -
A multimodal approach to the treatment of painful diabetic neuropathy. Case report
by: Ekaterina V. Mandra, et al.
Published: (2024-12-01) -
A back-up mechanism for replication
by: Godefroid Charbon, et al.
Published: (2025-05-01) -
Small fiber damage in patients with chemo-induced polyneuropathy
by: O. A. Tikhonova, et al.
Published: (2024-03-01)